These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10602841)

  • 1. Osteoblast numbers after calcitonin therapy: a retrospective study of paired biopsies obtained during long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Grigsby J; Chesnut Ill CH
    Calcif Tissue Int; 2000 Jan; 66(1):29-34. PubMed ID: 10602841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.
    Arlot ME; Jiang Y; Genant HK; Zhao J; Burt-Pichat B; Roux JP; Delmas PD; Meunier PJ
    J Bone Miner Res; 2008 Feb; 23(2):215-22. PubMed ID: 17922612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs.
    Monier-Faugere MC; Geng Z; Qi Q; Arnala I; Malluche HH
    J Bone Miner Res; 1996 Apr; 11(4):446-55. PubMed ID: 8992875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
    Lindsay R; Zhou H; Cosman F; Nieves J; Dempster DW; Hodsman AB
    J Bone Miner Res; 2007 Apr; 22(4):495-502. PubMed ID: 17227219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis.
    Parfitt AM; Villanueva AR; Foldes J; Rao DS
    J Bone Miner Res; 1995 Mar; 10(3):466-73. PubMed ID: 7785469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.
    Durchschlag E; Paschalis EP; Zoehrer R; Roschger P; Fratzl P; Recker R; Phipps R; Klaushofer K
    J Bone Miner Res; 2006 Oct; 21(10):1581-90. PubMed ID: 16995813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Baylink DJ; Matthews M; Nelp WB; Sisom K; Chesnut CH
    Metabolism; 1984 Apr; 33(4):295-303. PubMed ID: 6423929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
    Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
    Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Thompson ER; Chesnut CH; Baylink DJ
    Miner Electrolyte Metab; 1986; 12(4):246-54. PubMed ID: 3762511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis.
    Ma YL; Marin F; Stepan J; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Martínez G; Malouf J; Zeng QQ; Wan X; Recker RR
    Bone; 2011 May; 48(5):972-8. PubMed ID: 21262402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcitonin and vitamin D in osteoporosis.
    Palmieri GM; Pitcock JA; Brown P; Karas JG; Roen LJ
    Calcif Tissue Int; 1989 Sep; 45(3):137-41. PubMed ID: 2505903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate in osteoporosis.
    Reginster JY
    Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcitonin in the prevention and therapy of osteoporosis].
    Ringe JD
    Ther Umsch; 1991 Feb; 48(2):91-9. PubMed ID: 2035172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide.
    Lindsay R; Cosman F; Zhou H; Bostrom MP; Shen VW; Cruz JD; Nieves JW; Dempster DW
    J Bone Miner Res; 2006 Mar; 21(3):366-73. PubMed ID: 16491283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.